Huxley Medical

Huxley Medical, Inc. develops FDA-cleared wearable diagnostic patches and cloud-based software platforms for integrated cardiosleep assessment. The company's flagship product, SANSA® (Sleep Apnea and Nocturnal Symptom Assessment), is a single-use, wireless, cellular-enabled patch that captures nine channels of physiological data—including ECG, SpO2, heart rate, respiratory effort, chest movement, body position, actigraphy, snoring, and sleep/wake staging—to diagnose obstructive sleep apnea and detect cardiac arrhythmias including atrial fibrillation in a home-based setting. SANSA® has received FDA 510(k) clearance for sleep apnea testing, diagnostic ECG capabilities, and central sleep apnea detection. The device has been validated in multi-site clinical trials against gold-standard polysomnography (PSG). Huxley's software platform, Huxley HUB™, is a HIPAA-compliant cloud portal offering real-time data management, epoch-by-epoch sleep review, AI-powered auto-scoring at 3% and 4% hypopnea thresholds, customizable reporting templates, and direct report delivery to sleep specialists and cardiologists. The company targets sleep medicine practices, cardiology clinics, and primary care settings seeking to streamline sleep apnea diagnosis, reduce diagnostic backlogs, and integrate cardiosleep assessment without lengthy referrals or multiple in-clinic visits. SANSA Express™ offers direct-to-patient shipping with 24/7 live support. Regulatory credentials include FDA 510(k) clearance and HIPAA compliance. Manufacturing and service capabilities include cellular-enabled wearable patch design, cloud-native platform architecture, and direct patient logistics.